Journal Of Chemotherapy

杂志介绍

Journal Of Chemotherapy杂志介绍

《Journal Of Chemotherapy》是一本以English为主的未开放获取国际优秀期刊，中文名称化疗杂志，本刊主要出版、报道医学-INFECTIOUS DISEASES领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.9，最新CiteScore 指数为3.7。

本刊近期中国学者发表的论文主要有：

• Using Monte Carlo simulation to determine optimal dosing regimen for cefetamet sodium for injection.

  Author: Li C, Sun J, Miao J, Qin Y, Wang Y, Yu R, Xiao Y.

• Efficacy and safety of biapenem in treatment of infectious disease: a meta-analysis of randomized controlled trials.

  Author: Pei G, Yin W, Zhang Y, Wang T, Mao Y, Sun Y.

• NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer.

  Author: Liu K, Chen HL, Gu MM, You QS.

• Radiotherapy combined with chemotherapy versus radiotherapy alone for early stage nasal natural killer/T-cell lymphoma: a meta-analysis.

  Author: Zhang B, Zhu F, Liu X, Zhao J, Li M, Li Y, Huang J, Zou L, Chang Q.

英文介绍

Journal Of Chemotherapy杂志英文介绍

The Journal of Chemotherapy is an international multidisciplinary journal committed to the rapid publication of high quality, peer-reviewed, original research on all aspects of antimicrobial and antitumor chemotherapy.

The Journal publishes original experimental and clinical research articles, state-of-the-art reviews, brief communications and letters on all aspects of chemotherapy, providing coverage of the pathogenesis, diagnosis, treatment, and control of infection, as well as the use of anticancer and immunomodulating drugs.

Specific areas of focus include, but are not limited to:

· Antibacterial, antiviral, antifungal, antiparasitic, and antiprotozoal agents;

· Anticancer classical and targeted chemotherapeutic agents, biological agents, hormonal drugs, immunomodulatory drugs, cell therapy and gene therapy;

· Pharmacokinetic and pharmacodynamic properties of antimicrobial and anticancer agents;

· The efficacy, safety and toxicology profiles of antimicrobial and anticancer drugs;

· Drug interactions in single or combined applications;

· Drug resistance to antimicrobial and anticancer drugs;

· Research and development of novel antimicrobial and anticancer drugs, including preclinical, translational and clinical research;

· Biomarkers of sensitivity and/or resistance for antimicrobial and anticancer drugs;

· Pharmacogenetics and pharmacogenomics;

· Precision medicine in infectious disease therapy and in cancer therapy;

· Pharmacoeconomics of antimicrobial and anticancer therapies and the implications to patients, health services, and the pharmaceutical industry.